相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
FinnGen provides genetic insights from a well-phenotyped isolated population
Mitja Kurki et al.
NATURE (2023)
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
Ying Zhou et al.
NUCLEIC ACIDS RESEARCH (2022)
Antibiotics and mental health: The good, the bad and the ugly
Katherine Dinan et al.
JOURNAL OF INTERNAL MEDICINE (2022)
REGULATORY WATCH Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs
David Ochoa et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
Peng Ren et al.
FRONTIERS IN PHARMACOLOGY (2022)
Ten challenges for clinical translation in psychiatric genetics
Eske M. Derks et al.
NATURE GENETICS (2022)
Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts
Sharon L. Freshour et al.
NUCLEIC ACIDS RESEARCH (2021)
A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits
Christopher N. Foley et al.
NATURE COMMUNICATIONS (2021)
Symptom-level modelling unravels the shared genetic architecture of anxiety and depression
Jackson G. Thorp et al.
NATURE HUMAN BEHAVIOUR (2021)
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
Michelle Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Advancing the use of genome-wide association studies for drug repurposing
William R. Reay et al.
NATURE REVIEWS GENETICS (2021)
A major role for common genetic variation in anxiety disorders
Kirstin L. Purves et al.
MOLECULAR PSYCHIATRY (2020)
Reproducible Genetic Risk Loci for Anxiety: Results From similar to 200,000 Participants in the Million Veteran Program
Daniel F. Levey et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Minimal phenotyping yields genome-wide association signals of low specificity for major depression
Na Cai et al.
NATURE GENETICS (2020)
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani et al.
FRONTIERS IN PSYCHIATRY (2020)
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases
Na Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Enduring neurobehavioral effects induced by microbiota depletion during the adolescent period
Gilliard Lach et al.
TRANSLATIONAL PSYCHIATRY (2020)
Structural Basis of the Diversity of Adrenergic Receptors
Lu Qu et al.
CELL REPORTS (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism
Marion Soto et al.
MOLECULAR PSYCHIATRY (2018)
Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial
Jeffrey R. Strawn et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)
Sigma-1 receptor activation ameliorates anxiety-like behavior through NR2A-CREB-BDNF signaling pathway in a rat model submitted to single-prolonged stress
Li-Li Ji et al.
MOLECULAR MEDICINE REPORTS (2017)
Functional mapping and annotation of genetic associations with FUMA
Kyoko Watanabe et al.
NATURE COMMUNICATIONS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
Gut microbiota's effect on mental health: The gut-brain axis
Megan Clapp et al.
CLINICS AND PRACTICE (2017)
Activation of Sigma-1 receptor ameliorates anxiety-like behavior and cognitive impairments in a rat model of post-traumatic stress disorder
Li-Li Ji et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Integrative approaches for large-scale transcriptome-wide association studies
Alexander Gusev et al.
NATURE GENETICS (2016)
Gene expression elucidates functional impact of polygenic risk for schizophrenia
Menachem Fromer et al.
NATURE NEUROSCIENCE (2016)
Antibiotic Exposure and the Risk for Depression, Anxiety, or Psychosis: A Nested Case-Control Study
Ido Lurie et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
MAGMA: Generalized Gene-Set Analysis of GWAS Data
Christiaan A. de Leeuw et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel
Olivier Delaneau et al.
NATURE COMMUNICATIONS (2014)
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
Claudia Giambartolomei et al.
PLOS GENETICS (2014)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Global prevalence of anxiety disorders: a systematic review and meta-regression
A. J. Baxter et al.
PSYCHOLOGICAL MEDICINE (2013)
Development of a large-scale de-identified DNA biobank to enable personalized medicine
D. M. Roden et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent:: Relevance to its anti depressant/anxiolytic-like profile
Y. Claustre et al.
NEUROSCIENCE (2008)
Confirmation of antidepressant potential of the selective β3 adrenoceptor agonist amibegron in an animal model of depression
David H. Overstreet et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder
Eduardo Dunayevich et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Stimulation of the β3-adrenoceptor as a novel treatment strategy for anxiety and depressive disorders
Jeanne Stemmelin et al.
NEUROPSYCHOPHARMACOLOGY (2008)
A brief measure for assessing generalized anxiety disorder -: The GAD-7
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Treatment-resistant anxiety disorders
A. Bystritsky
MOLECULAR PSYCHIATRY (2006)
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
CJ Swanson et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress
DD Schoepp et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2003)
A review and meta-analysis of the genetic epidemiology of anxiety disorders
JM Hettema et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)